Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 17.04.13 in Vol 2, No 1 (2013): Jan-Jun

This paper is in the following e-collection/theme issue:

Works citing "Severe Loss of Appetite in Amyotrophic Lateral Sclerosis Patients: Online Self-Assessment Study"

Teresa Holm, André Maier, Paul Wicks, Dirk Lang, Peter Linke, Christoph Münch, Laura Steinfurth, Robert Meyer, Thomas Meyer

Interact J Med Res 2013 (Apr 17); 2(1):e8 

According to Crossref, the following articles are citing this article (DOI 10.2196/ijmr.2463):

(note that this is only a small subset of citations)

  1. Lisiecka D, Kelly H, Jackson J. How do people with Motor Neurone Disease experience dysphagia? A qualitative investigation of personal experiences. Disability and Rehabilitation 2021;43(4):479
    CrossRef
  2. Ahmed RM, Ke YD, Vucic S, Ittner LM, Seeley W, Hodges JR, Piguet O, Halliday G, Kiernan MC. Physiological changes in neurodegeneration — mechanistic insights and clinical utility. Nature Reviews Neurology 2018;14(5):259
    CrossRef
  3. Shimizu T, Nakayama Y, Matsuda C, Haraguchi M, Bokuda K, Ishikawa-Takata K, Kawata A, Isozaki E. Prognostic significance of body weight variation after diagnosis in ALS: a single-centre prospective cohort study. Journal of Neurology 2019;266(6):1412
    CrossRef
  4. Ngo ST, van Eijk RP, Chachay V, van den Berg LH, McCombe PA, Henderson RD, Steyn FJ. Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2019;20(7-8):497
    CrossRef
  5. Moglia C, Calvo A, Grassano M, Canosa A, Manera U, D'Ovidio F, Bombaci A, Bersano E, Mazzini L, Mora G, Chiò A. Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort. Journal of Neurology, Neurosurgery & Psychiatry 2019;90(6):666
    CrossRef
  6. Zarotti N, Coates E, McGeachan A, Williams I, Beever D, Hackney G, Norman P, Stavroulakis T, White D, White S, Halliday V, McDermott C. Health care professionals’ views on psychological factors affecting nutritional behaviour in people with motor neuron disease: A thematic analysis. British Journal of Health Psychology 2019;24(4):953
    CrossRef
  7. Tracey T, Kirk S, Steyn F, Ngo S. The role of lipids in the central nervous system and their pathological implications in amyotrophic lateral sclerosis. Seminars in Cell & Developmental Biology 2021;112:69
    CrossRef
  8. Tokudome Y, Okumura K, Kumagai Y, Hirano H, Kim H, Morishita S, Watanabe Y. Development of the Japanese version of the Council on Nutrition Appetite Questionnaire and its simplified versions, and evaluation of their reliability, validity, and reproducibility. Journal of Epidemiology 2017;27(11):524
    CrossRef
  9. Colldén G, Tschöp M, Müller T. Therapeutic Potential of Targeting the Ghrelin Pathway. International Journal of Molecular Sciences 2017;18(4):798
    CrossRef
  10. Janse van Mantgem MR, van Eijk RPA, van der Burgh HK, Tan HHG, Westeneng H, van Es MA, Veldink JH, van den Berg LH. Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: a population-based study. Journal of Neurology, Neurosurgery & Psychiatry 2020;91(8):867
    CrossRef
  11. Nakayama Y, Shimizu T, Matsuda C, Haraguchi M, Hayashi K, Bokuda K, Nagao M, Kawata A, Ishikawa-Takata K, Isozaki E. Body weight variation predicts disease progression after invasive ventilation in amyotrophic lateral sclerosis. Scientific Reports 2019;9(1)
    CrossRef
  12. Czell D, Baldinger R, Schneider U, Neuwirth C, Weber M. The role of the SenseWear device and ghrelin for metabolism in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2016;17(3-4):295
    CrossRef
  13. Mezoian T, Belt E, Garry J, Hubbard J, Breen CT, Miller L, Levine‐Weinberg M, Nalipinski P, Sullivan S, Chan J, Wills A. Loss of appetite in amyotrophic lateral sclerosis is associated with weight loss and decreased calorie consumption independent of dysphagia. Muscle & Nerve 2020;61(2):230
    CrossRef
  14. Scagnelli CN, Howard DB, Bromberg MB, Kasarskis EJ, Matthews DE, Mitsumoto HM, Simmons Z, Tandan R. Hydration measured by doubly labeled water in ALS and its effects on survival. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2018;19(3-4):220
    CrossRef
  15. Shimizu T, Ishikawa-Takata K, Sakata A, Nagaoka U, Ichihara N, Ishida C, Nakayama Y, Komori T, Nishizawa M. The measurement and estimation of total energy expenditure in Japanese patients with ALS: a doubly labelled water method study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2017;18(1-2):37
    CrossRef
  16. Ngo S, Steyn F, McCombe P. Body mass index and dietary intervention: Implications for prognosis of amyotrophic lateral sclerosis. Journal of the Neurological Sciences 2014;340(1-2):5
    CrossRef
  17. Dorst J, Cypionka J, Ludolph AC. High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: A prospective interventional study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2013;14(7-8):533
    CrossRef
  18. Chalmers J, Tung Y, Liu C, O'Kane C, O'Rahilly S, Yeo G. A multicomponent screen for feeding behaviour and nutritional status in Drosophila to interrogate mammalian appetite-related genes. Molecular Metabolism 2021;43:101127
    CrossRef
  19. Ngo ST, Wang H, Henderson RD, Bowers C, Steyn FJ. Ghrelin as a treatment for amyotrophic lateral sclerosis. Journal of Neuroendocrinology 2021;33(7)
    CrossRef
  20. Tefera TW, Steyn FJ, Ngo ST, Borges K. CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?. Cell & Bioscience 2021;11(1)
    CrossRef
  21. Wang Y, Ye S, Chen L, Tang L, Fan D. Loss of appetite in patients with amyotrophic lateral sclerosis is associated with weight loss and anxiety/depression. Scientific Reports 2021;11(1)
    CrossRef
  22. Waheed W, Khan F, Naud S, Kasarskis E, Matthews D, Tandan R. Urine specific gravity to identify and predict hydration need in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2022;23(5-6):407
    CrossRef
  23. Guillot SJ, Bolborea M, Dupuis L. Dysregulation of energy homeostasis in amyotrophic lateral sclerosis. Current Opinion in Neurology 2021;34(5):773
    CrossRef
  24. Sarmet M, Kabani A, Maragakis NJ, Mehta AK. Appetite and quality of life in amyotrophic lateral sclerosis: A scoping review. Muscle & Nerve 2022;66(6):653
    CrossRef
  25. Nelson AT, Trotti D. Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis. Neurotherapeutics 2022;19(4):1102
    CrossRef
  26. Nagaoka U, Shimizu T, Uchihara T, Komori T, Hosoda H, Takahashi K. Decreased plasma ghrelin in male ALS patients is associated with poor prognosis. Neuroscience Research 2022;177:111
    CrossRef
  27. Chiò A, Canosa A, Calvo A, Moglia C, Cicolin A, Mora G. Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis. Expert Review of Neurotherapeutics 2021;21(12):1419
    CrossRef
  28. Ferrer-Donato A, Contreras A, Frago LM, Chowen JA, Fernandez-Martos CM. Alterations in Leptin Signaling in Amyotrophic Lateral Sclerosis (ALS). International Journal of Molecular Sciences 2021;22(19):10305
    CrossRef
  29. Maier A, Münch C, Meyer T. Der Einsatz von Patient-reported Outcome Measures (PROM) und die Perspektive digitaler Biomarker bei der Amyotrophen Lateralsklerose. Klinische Neurophysiologie 2023;54(01):28
    CrossRef
  30. Rogers CQ, Ramirez M, Landon CS, DeBlasi JM, Koutnik AP, Ari C, D’Agostino DP. A Glutamate Scavenging Protocol Combined with Deanna Protocol in SOD1-G93A Mouse Model of ALS. Nutrients 2023;15(8):1821
    CrossRef
  31. Tzeplaeff L, Wilfling S, Requardt MV, Herdick M. Current State and Future Directions in the Therapy of ALS. Cells 2023;12(11):1523
    CrossRef
  32. Maksimovic K, Youssef M, You J, Sung H, Park J. Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models. Biomolecules 2023;13(5):863
    CrossRef

According to Crossref, the following books are citing this article (DOI 10.2196/ijmr.2463):

  1. Stavroulakis T, McDermott CJ. Nutrition in Neurologic Disorders. 2017. Chapter 6:91
    CrossRef
  2. Ngo ST, Steyn FJ, McCombe PA, Borges K. Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease. 2015. :355
    CrossRef
  3. Ahmed RM, Steyn F, Dupuis L. The Human Hypothalamus - Middle and Posterior Region. 2021. :327
    CrossRef
  4. Holdom CJ, Steyn FJ, Henderson RD, McCombe PA, Rogers M, Ngo ST. Neurodegenerative Diseases Biomarkers. 2022. Chapter 11:263
    CrossRef